Utility of serum YKL-40 levels for identification of patients with asthma and COPD

Utility of serum YKL-40 levels for identification of patients with asthma and COPD

Bibliographic Details
Main Authors:	Yasuhiro Gon, Shuichiro Maruoka, Reiko Ito, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Tomohiro Hattori, Mai Takahashi, Mari Hikichi, Shu Hashimoto
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	Allergology International
Online Access:	http://www.sciencedirect.com/science/article/pii/S132389301730014X

Similar Items

Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap
by: Toshihiro Shirai, et al.
Published: (2021-01-01)

Long-term course of serum total and free IgE levels in severe asthma patients treated with omalizumab
by: Yasuhiro Gon, et al.
Published: (2018-04-01)

Serum free IgE guided dose reduction of omalizumab: a case report
by: Yasuhiro Gon, et al.
Published: (2017-08-01)

Asthma and COPD overlap pathophysiology of ACO
by: Mari Hikichi, et al.
Published: (2018-04-01)

Increased extracellular vesicle miRNA-466 family in the bronchoalveolar lavage fluid as a precipitating factor of ARDS
by: Sotaro Shikano, et al.
Published: (2019-06-01)

DsRNA disrupts airway epithelial barrier integrity through down-regulation of claudin members
by: Yasuhiro Gon, et al.
Published: (2016-09-01)

Autophagy, selective autophagy, and necroptosis in COPD
by: Mizumura K, et al.
Published: (2018-10-01)

Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
by: Jing Wang, et al.
Published: (2018-03-01)

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
by: Tong X, et al.
Published: (2018-01-01)

The Role of YKL-40 in the Progression of Glioblastoma
by: Francescone, Ralph Anthony
Published: (2013)

The role of YKL-40 in the progression of glioblastoma
by: Francescone III, Ralph A
Published: (2013)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
by: Camilla Bjørnbak Holst, et al.
Published: (2020-04-01)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
by: Anna Villar-Piqué, et al.
Published: (2019-07-01)

Study of serum YKL-40 in children with bronchial
by: Iman A. Mohammed, et al.
Published: (2016-03-01)

The role of YKL-40 in a cancerous process
by: Agnieszka Rusak, et al.
Published: (2016-12-01)

YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010-07-01)

CpG oligodeoxynucleotides enhance airway epithelial barrier integrity
by: Yasuhiro Gon, et al.
Published: (2017-09-01)

Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab
by: Reiko Ito, et al.
Published: (2014-01-01)

Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.
by: Yuki Sakazaki, et al.
Published: (2011-01-01)

The value of YKL-40 in ischemic heart disease patients
by: Doaa S.E Zaky, et al.
Published: (2016-01-01)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
by: Rathcke Camilla, et al.
Published: (2009-01-01)

Study on the correlation between YKL-40 and Parkinson's disease
by: Xin-xin YANG, et al.
Published: (2014-12-01)

SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014-06-01)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
by: Franc Llorens, et al.
Published: (2017-11-01)

Gene expression analysis in airway-secreting extracellular vesicles upon house dust mite exposure
by: Yasuhiro Gon, et al.
Published: (2016-09-01)

Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection
by: Tuula K. Outinen, et al.
Published: (2019-08-01)

Association of YKL-40 with endothelial dysfunction in patients with essential hypertension
by: Qing-hong Ji, et al.
Published: (2020-09-01)

YKL-40 in Asthma and its Correlation with Different Clinical Parameters
by: Mohammadali Saba, et al.
Published: (2014-08-01)

The Relationship between Serum YKL-40 Levels and Severity of Asthma
by: Serap Duru, et al.
Published: (2013-09-01)

Overexpression of chitinase like protein YKL-40 in leukemia patients
by: Anil K. Hurmale, et al.
Published: (2013-01-01)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
by: Rong eShao
Published: (2013-05-01)

Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease
by: Xue Xu, et al.
Published: (2014-08-01)

YKL-40 related genetic polymorphisms and coronary artery disease
by: Ke-Hsin, Ting 丁革新, et al.
Published: (2016)

YKL-40 Correlates with Soluble CD 40 Ligand in Old Myocardial Infarction with Hypertension
by: Diah Kumalasari, et al.
Published: (2012-04-01)

YKL-40 as a Novel Factor Associated with Inflammation and Catabolic Mechanisms in Osteoarthritic Joints
by: Tuija Väänänen, et al.
Published: (2014-01-01)

YKL-40 Is Associated With Ultrasound-Determined Carotid Atherosclerotic Plaque Instability
by: Yu Wang, et al.
Published: (2021-02-01)

Serum YKL-40 is associated with the severity of coronary artery disease and hypertension
by: Yu Xing, et al.
Published: (2020-11-01)

Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children
by: Yoowon Kwon, et al.
Published: (2020-01-01)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
by: Dong Wang, et al.
Published: (2012-03-01)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
by: Dong Wang, et al.
Published: (2012-03-01)